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Fluorogenic Assay
Inhibition assays were performed in flat-bottomed 384-well μ-clear plates (Greiner Bio-One) with a final volume of 25 μL, and using 50 mM HEPES, pH 7.5 containing 0.01% (v/v) Triton X-100 as the assay buffer. Ldt Mt2 (100 nM) was treated with a range of inhibitor concentrations, and the mixture was incubated for 0, 10 or 60 minutes. Following this pre-incubation, fluorogenic probe 1 (25 μM) 2 was added, and the mixture was incubated for a further 30 minutes. The fluorescence signal was then measured using a BMG Labtech PHERAstar FS with λ ex = 480 nm and λ em = 520 nm using the bottom optic. All reactions were carried out in quadruplicate, and controls without inhibitor and without Ldt Mt2 were included. Inhibition results were normalised using the no inhibitor and no enzyme controls. Dose-response analysis was performed using Prism (GraphPad) with the log(inhibitor) vs normalized response --variable slope model. Data points were plotted as mean average with the standard deviation as the error bars.
Mass Spectrometry
Mass spectrometric analyses were performed using an Agilent 6550 system equipped with a RapidFire sampler. Samples (100 µL) were prepared in 50 mM Tris, pH 7.5, consisting of 3 µM Ldt Mt2 and either 6 µM or 30 µM of the relevant inhibitor, as specified elsewhere.
X-ray Crystallography
Purified Ldt Mt2 Δ1-55 (approx. 1 mM; His-tag cleaved) in 50 mM Tris, pH 8.0, 100 mM NaCl was used for crystallography. Crystallisation trials were set up using the sitting drop vapour diffusion method with the JCSG+ broad screen (Molecular Dimensions). A structure of Ldt Mt2 Δ1-55 (PDB 6RLG) was solved using a crystal S4 obtained from a well solution consisting of 0.2 M ammonium nitrate and 20 % w/v PEG 3350. A structure of Ldt Mt2 Δ1-55 in complex with ebselen (PDB 6RRM) was solved by soaking the crystals obtained above with 15 mM ebselen. Data were collected at 100 K at the Diamond Light Source synchrotron IO4-1 beamline. Data were indexed and integrated with XDS, and scaled using SHELX. 3 Phaser was used to solve the structure by molecular replacement, 4 using PDB entry 5DU7 as a search model. 5 Fitting and refinement were carried out using COOT 6 and PHENIX 7 until R work and R free no longer converged. The final statistics for data collection and refinement are listed in Table S2 . Figure S1 . Enzymatic activity of the L,D-transpeptidases. 9 Scheme showing 3→3 (Figure S3 ). Note that the products formed by the reaction of Ldt Mt2 with PhSe(O)OH are presently unknown. S14
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